Valneva (VALN) News Today $3.99 -0.36 (-8.28%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Health Talk: Why an India-made Chikungunya vaccine is good newsDecember 21 at 4:25 AM | msn.comSII to manufacture French firm’s vaccine for chikungunyaDecember 20 at 11:24 PM | msn.comValneva and Serum Institute of India Collaborate to Tackle Chikungunya in AsiaDecember 19 at 10:15 PM | markets.businessinsider.comSerum Institute of India to manufacture French company Valneva’s Chikungunya vaccineDecember 19 at 10:15 PM | msn.comValneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of IndiaDecember 19 at 5:06 AM | markets.businessinsider.comValneva SE (NASDAQ:VALN) Short Interest Up 111.0% in NovemberValneva SE (NASDAQ:VALN - Get Free Report) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 30,600 shares, an increase of 111.0% from the November 15th total of 14,500 shares. Based on an average daily volume of 23,500 shares, the short-interest ratio is presently 1.3 days. Currently, 0.0% of the shares of the stock are sold short.December 12, 2024 | marketbeat.comValneva Highlights Chikungunya’s Global Economic ImpactDecember 4, 2024 | tipranks.comValneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical JournalDecember 4, 2024 | globenewswire.comValneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®December 3, 2024 | globenewswire.comValneva submits label extension application for chikungunya vaccine to FDANovember 27, 2024 | markets.businessinsider.comValneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDANovember 26, 2024 | globenewswire.comWhat you need to know about the new Chikungunya vaccine and where to get it in B.C.November 18, 2024 | msn.comEuropean Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health DepartmentNovember 16, 2024 | msn.comFrance stocks lower at close of trade; CAC 40 down 0.14%November 14, 2024 | msn.comValneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2November 13, 2024 | globenewswire.comValneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare ConferencesNovember 12, 2024 | markets.businessinsider.comKepler Capital Remains a Buy on Valneva (0OB3)November 10, 2024 | markets.businessinsider.comValneva SE Reports Profitable Nine-Month PerformanceNovember 10, 2024 | markets.businessinsider.comCullinan Management: Strong Financials and Promising Pipeline Drive Buy RatingNovember 8, 2024 | markets.businessinsider.comChimerix’s Positive Phase 3 Trial Progress and Strong Financial Position Justify ‘Buy’ RatingNovember 8, 2024 | markets.businessinsider.comValneva Reports Nine-Month 2024 Financial Results and Provides Corporate UpdatesNovember 7, 2024 | globenewswire.comValneva SE (VALN) Q3 2024 Earnings Report Preview: What to Look ForNovember 6, 2024 | finance.yahoo.comValneva (VALN) to Release Quarterly Earnings on ThursdayValneva (NASDAQ:VALN) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports.November 5, 2024 | marketbeat.comValneva’s Chikungunya Vaccine Gains Scientific SpotlightOctober 22, 2024 | markets.businessinsider.comValneva to Present on Chikungunya at Several Leading Scientific ConferencesOctober 21, 2024 | globenewswire.comValneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4VOctober 16, 2024 | globenewswire.comVaccine producer supports local cancer charity Team Jak FoundationOctober 15, 2024 | msn.comBrokers Set Expectations for Valneva SE's FY2024 Earnings (NASDAQ:VALN)Valneva SE (NASDAQ:VALN - Free Report) - Investment analysts at HC Wainwright decreased their FY2024 earnings estimates for Valneva in a research note issued to investors on Friday, October 11th. HC Wainwright analyst E. White now forecasts that the company will earn $0.00 per share for the year,October 14, 2024 | marketbeat.comBuy Rating for VALN: Strong Vaccine Pipeline and Financial UpsideOctober 11, 2024 | markets.businessinsider.comHigh Growth Tech Stocks In France October 2024October 11, 2024 | uk.finance.yahoo.comValneva (NASDAQ:VALN) Price Target Cut to $20.00HC Wainwright cut their price objective on Valneva from $23.00 to $20.00 and set a "buy" rating on the stock in a research report on Friday.October 11, 2024 | marketbeat.comValneva Scotland supports local cancer charity Team Jak FoundationOctober 10, 2024 | msn.comValneva Hosts Investor Day in New York CityOctober 10, 2024 | globenewswire.comValneva SE (INRLF) (H1 2024) Earnings Call Highlights: Navigating Growth Amidst Revenue ChallengesOctober 9, 2024 | finance.yahoo.comExclusive Networks And 2 High Growth Tech Stocks In FranceOctober 9, 2024 | uk.finance.yahoo.comValneva (NASDAQ:VALN) Stock Quotes, Forecast and News SummaryOctober 3, 2024 | benzinga.comValneva to Host Investor Day in New York on Thursday, October 10, 2024 at 10:00 AM ETOctober 3, 2024 | globenewswire.comHigh Growth Tech Stocks In France Featuring Bolloré And Two MoreSeptember 30, 2024 | finance.yahoo.comValneva’s Growth Prospects and Market Undervaluation Justify a Buy RatingSeptember 27, 2024 | markets.businessinsider.comValneva SE to Post Q3 2024 Earnings of ($0.29) Per Share, HC Wainwright Forecasts (NASDAQ:VALN)Valneva SE (NASDAQ:VALN - Free Report) - Analysts at HC Wainwright increased their Q3 2024 EPS estimates for Valneva in a research report issued to clients and investors on Wednesday, September 25th. HC Wainwright analyst E. White now forecasts that the company will post earnings per share of ($0September 27, 2024 | marketbeat.comBuy Rating Affirmed for Valneva Amidst Promising Vaccine Development and Financial ProspectsSeptember 25, 2024 | markets.businessinsider.comIn-Depth Examination Of 6 Analyst Recommendations For ValnevaSeptember 25, 2024 | benzinga.comHC Wainwright Cuts Valneva (NASDAQ:VALN) Price Target to $23.00HC Wainwright lowered their price objective on Valneva from $26.00 to $23.00 and set a "buy" rating on the stock in a research report on Wednesday.September 25, 2024 | marketbeat.comFrance stocks mixed at close of trade; CAC 40 up 0.10%September 24, 2024 | msn.comValneva SE (AYJ.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comValneva Scotland glows orange for World Patient Safety DaySeptember 18, 2024 | msn.comValneva Seeks Approval To Expand IXCHIQ Chikungunya Vaccine Use To Adolescents In Europe And CanadaSeptember 18, 2024 | markets.businessinsider.comValneva eyes teenage label for chikungunya vaccine in Europe and CanadaSeptember 18, 2024 | finance.yahoo.comValneva Submits Label Extension Applications for its Chikungunya Vaccine, IXCHIQ®, to EMA and Health CanadaSeptember 18, 2024 | globenewswire.comKepler Capital Sticks to Their Buy Rating for Valneva (0OB3)September 15, 2024 | markets.businessinsider.com Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss. Click Here to get the full details about Crypto’s Hidden Gem VALN Media Mentions By Week VALN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VALN News Sentiment▼0.330.60▲Average Medical News Sentiment VALN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VALN Articles This Week▼54▲VALN Articles Average Week Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CALT News ANIP News SNDX News SPRY News RCKT News AVDL News BCYC News COLL News SEPN News ZYME News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VALN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valneva SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Valneva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
